
Molina Healthcare (MOH) is upgraded to Buy with ~20% upside, driven by strategic ACA exit and Medicaid strength. MOH's Medicaid segment outperforms peers with a 92.7% Medical Care Ratio, while ACA underperformance is being addressed by management. Management guides for 13–15% EPS growth and at least $5.25 EPS in 2025, targeting $10–12 EPS in 2027.










